LAVIV Wins a 2011 Allure Best of Beauty Award
Fibrocell Science, Inc. , a cell therapy company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that LAVIV(TM) (azficel-T) has been named a 2011 Allure Breakthrough Award winner. LAVIV is a revolutionary new treatment for “smile line” wrinkles made from a person’s own skin cells that was recently FDA-approved.
The patented technology behind LAVIV is an advanced process that extracts a person’s fibroblast cells from a small skin sample and multiplies them in the Fibrocell Science lab. In normal skin, fibroblasts are responsible for producing collagen. LAVIV is the resulting formulation of a person’s own fibroblast cells, which is then injected into smile line wrinkles — the lines that run from the sides of the nose to the corners of the mouth. Each person’s formulation of LAVIV is unique because it is made from their own cells.
“We are thrilled that Allure recognized LAVIV with the Breakthrough Award. LAVIV offers a very new, highly personalized approach to treating smile line wrinkles, which is clinically proven to be safe and effective,” said David Pernock, Fibrocell Science Chairman and CEO.
Allure, the first and only magazine devoted to beauty, publishes its Best of Beauty Awards annually in the October issue. LAVIV is one of 14 Big Breakthrough products and treatments honored by Allure’s editorial staff.
About LAVIV(TM) (azficel-T) LAVIV was approved by the FDA on June 21, 2011 for the improvement of the appearance of moderate to severe smile line (nasolabial fold) wrinkles in adults.
Important Safety Information LAVIV is made especially for you from your own skin cells. Using someone else’s cells can cause a serious reaction. Do not let anyone else use your LAVIV.
The most common side effects of LAVIV are at the injection-site, including redness, bruising, swelling, pain, bleeding, lumps, irritation, and itchiness. In clinical trials with LAVIV, most injection-site adverse reactions resolved within one week and most required no treatment.
Your health care provider will help you to decide whether you are a candidate for LAVIV and may help you avoid some of the adverse reactions from LAVIV. Before getting LAVIV, tell your healthcare provider if you have any medical problems including allergic reactions to any drugs or food, bleeding disorders or take blood-thinning medicines like aspirin, ibuprofen, or coumadin, keloids or excessive scarring, skin cancer or any malignancy, genetic disorders affecting your skin, immune problems or take medicines that affect your immune system, or any other illness or medical problem. The full Prescribing Information for LAVIV includes additional warnings about adverse reactions that occurred in less than 1% of patients following LAVIV treatment in clinical trials. Talk to your healthcare provider about these warnings.
Please tell your healthcare provider if you are allergic to the antibiotics amphotericin or gentamicin, bovine materials (products made from cattle), or dimethyl sulfoxide (DMSO). Do not use LAVIV if you have a skin infection on your face because LAVIV treatment can make the infection worse.
For more information about LAVIV, please see the Full Prescribing Information at www.mylaviv.com.
About Fibrocell Science, Inc. Fibrocell Science, Inc. is a cell therapy company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well its innovative cellular processing technology and manufacturing excellence. For additional information, please visit www.fibrocellscience.com.
See Also:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
[…] Fibrocell Science, Inc. , a cell therapy company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that it has begun the launch of LAVIV (azficel-T) in major metropolitan areas throughout the U.S. LAVIV is a revolutionary treatment for “smile line” wrinkles made from a person’s own skin cells and was approved by the FDA on June 21, 2011 as the first and only personalized cell therapy for use in aesthetics. LAVIV was recently named a 2011 Allure Best of Beauty Award winner in the magazine’s annual cover story (October 2011 issue). […]